These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Ia- macrophages and cytokine networks contribute to tumor-induced suppression of CD4+ autoreactive T cells. Walker TM; Yurochko AD; Burger CJ; Elgert KD Immunol Invest; 1993 Apr; 22(3):169-87. PubMed ID: 8099569 [TBL] [Abstract][Full Text] [Related]
9. Variations in macrophage antigen phenotype: a correlation between Ia antigen reduction and immune dysfunction during tumor growth. Garner RE; Malick AP; Elgert KD J Leukoc Biol; 1986 Nov; 40(5):561-74. PubMed ID: 3464674 [TBL] [Abstract][Full Text] [Related]
10. Tumor growth changes the contribution of granulocyte-macrophage colony-stimulating factor during macrophage-mediated suppression of allorecognition. Walker TM; Yurochko AD; Burger CJ; Elgert KD Immunobiology; 1992 Sep; 185(5):427-39. PubMed ID: 1452214 [TBL] [Abstract][Full Text] [Related]
11. Normal and tumor-bearing host macrophage responses: variability in accessory function, surface markers, and cell-cycle kinetics. Askew D; Yurochko AD; Burger CJ; Elgert KD Immunol Lett; 1990; 24(1):21-9. PubMed ID: 1695610 [TBL] [Abstract][Full Text] [Related]
12. Normal and tumor-bearing host splenic macrophage responses to lipopolysaccharide. Yurochko AD; Askew D; Burger CJ; Elgert KD Immunol Invest; 1990 Feb; 19(1):41-55. PubMed ID: 1692569 [TBL] [Abstract][Full Text] [Related]
13. Tumor growth alters macrophage responsiveness to macrophage colony-stimulating factor during reactivity against allogeneic and syngeneic MHC class II molecules. Walker TM; Burger CJ; Elgert KD Immunol Invest; 1993; 22(6-7):463-76. PubMed ID: 8262568 [TBL] [Abstract][Full Text] [Related]
14. Tumor growth changes responsiveness to and production of granulocyte-macrophage colony-stimulating factor during recognition of self MHC class II molecules. Walker TM; Burger CJ; Elgert KD Oncol Res; 1992; 4(11-12):455-65. PubMed ID: 1299376 [TBL] [Abstract][Full Text] [Related]
15. Macrophage-derived prostaglandin E modulation of the mixed-lymphocyte reaction: an anomaly of increased production and decreased T-cell susceptibility during tumor growth. Denbow CJ; Conroy JM; Elgert KD Cell Immunol; 1984 Mar; 84(1):1-13. PubMed ID: 6230157 [TBL] [Abstract][Full Text] [Related]
16. Cytokines and suppressor macrophages cause tumor-bearing host CD8+ T cells to suppress recognition of allogeneic and syngeneic MHC class II molecules. Walker TM; Yurochko AD; Burger CJ; Elgert KD J Leukoc Biol; 1992 Dec; 52(6):661-9. PubMed ID: 1464737 [TBL] [Abstract][Full Text] [Related]
17. Increased sensitivity of tumor-bearing host macrophages to interleukin-10: a counter-balancing action to macrophage-mediated suppression. Alleva DG; Burger CJ; Elgert KD Oncol Res; 1994; 6(4-5):219-28. PubMed ID: 7841545 [TBL] [Abstract][Full Text] [Related]
18. Modulation of alloreactivity by Mac-1+, -2+, and -3+ macrophages from normal and tumor-bearing hosts: flow cytofluorometrically separated macrophages. Askew D; Burger CJ; Elgert KD Immunobiology; 1990 Dec; 182(1):1-10. PubMed ID: 2151512 [TBL] [Abstract][Full Text] [Related]
19. Changes in splenic macrophage Mac antigen expression during tumor growth: a kinetic study of accessory cell function and antigen-defined phenotypes. Garner RE; Elgert KD J Leukoc Biol; 1986 Dec; 40(6):709-24. PubMed ID: 3537182 [TBL] [Abstract][Full Text] [Related]
20. Two-color flow cytometric analysis of the expression of MAC and MHC class II antigens on macrophages during tumor growth. Yurochko AD; Burger CJ; Elgert KD Cytometry; 1990; 11(6):725-35. PubMed ID: 2200657 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]